Intracardiac Thrombus Following Rivaroxaban Treatment in a Patient with Atrial Fibrillation Associated with Rheumatic Heart Disease.
Administration, Oral
Aged
Anticoagulants
/ administration & dosage
Atrial Fibrillation
/ diagnosis
Brain Infarction
/ etiology
Drug Substitution
Factor Xa Inhibitors
/ administration & dosage
Humans
Intracranial Embolism
/ etiology
Male
Rheumatic Heart Disease
/ complications
Rivaroxaban
/ administration & dosage
Thrombosis
/ diagnostic imaging
Treatment Outcome
Warfarin
/ administration & dosage
Direct oral anticoagulants
atrial fibrillation
intracardiac thrombus
rheumatic heart disease
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
28
05
2019
revised:
13
07
2019
accepted:
25
07
2019
pubmed:
21
8
2019
medline:
18
12
2019
entrez:
21
8
2019
Statut:
ppublish
Résumé
We report a case of atrial fibrillation with rheumatic heart disease (RHD) who had intracardiac thrombus and cardiogenic cerebral embolism with rivaroxaban therapy. Intracardiac thrombus disappeared after switching from rivaroxaban to warfarin. Patients of RHD have the possibility of gradual progression of valvular disease even if they are old, so we need to distinguish nonvalvular atrial fibrillation from RHD before starting direct oral anticoagulants.
Identifiants
pubmed: 31427189
pii: S1052-3057(19)30378-7
doi: 10.1016/j.jstrokecerebrovasdis.2019.104325
pii:
doi:
Substances chimiques
Anticoagulants
0
Factor Xa Inhibitors
0
Warfarin
5Q7ZVV76EI
Rivaroxaban
9NDF7JZ4M3
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
104325Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.